MI
BHVN icon

Motiv8 Investments’s Biohaven BHVN Stock Holding History

Motiv8 Investments’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$0 Buy
+40
New +$496 ﹤0.01% 913

Other funds holding BHVN

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $173M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Motiv8 Investments's BHVN Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Biohaven (BHVN) in Q4 2025: 40 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #913 among its holdings.

272 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • Motiv8 Investments held 40 shares of Biohaven worth $0 as of Q4 2025.
  • Biohaven was a new Motiv8 Investments position in Q4 2025.
  • Biohaven made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #913 holding.
  • 272 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.